Regulators, unite! Hamburg urges global cooperation

Share this article:

Drug regulators are seeking a global approach. Regulatory Focus reports that plans for a “new regulatory supergroup” have been in the works for some time, but that FDA Commissioner Margaret Hamburg announced the organization this week in London at the Medicines and Healthcare Product Respiratory Agency's Annual Lecture.

RF says Hamburg used the FDA's global needs as context—an issue she also brought up when recapping her visit to India and the need for global partnerships—and urged that regulators work together and draw on each other's resources for support.

“What we really need for the future is a public health safety net for consumers around the world that is created, supported and maintained by a global alliance of regulators,” she said.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.